International Journal of Geriatric Psychiatry, on-line first June 29. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment. (Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JLC, Chertkow H. Montreal Cognitive Assessment and Mini-Mental State Examination Reliable Change Indices in Healthy Older Adults. MoCA Cognition 4896 Taschereau Blvd Suite 230 Greenfield Park, Québec Canada J4V 2J2. ↑ Kopecek, M., Bezdicek, O., Sulc, Z., Lukavsky,J., & Stepankova, H.Applied Neuropsychology: Adult, 24(1), 23-29. Montreal Cognitive Assessment (MoCA): Normative Data for Old and Very Old Czech Adults. ↑ Kopecek, M., Stepankova, H., Lukavsky, J., Ripova, D., Nikolai, T., & Bezdicek, O.Screeningové škály pro hodnocení demence. (2006) Montrealský kognitivni test /MoCA/: přínos k diagnostice predemencí. Journal of the American Geriatric Society, 53(4), 695–699. The Montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment. A., Bedirian, V., Charbonneau, S., Whitehead, V., Collin,I.,…Chertkow, H. REKTOROVÁ, PH.D, Irena. Screeningové škály pro hodnocení demence. We observe the highest scores in cognitively healthy individuals. In persons with mild cognitive impairment, attention is not impaired, but scores on other items are also low.
People with Alzheimer's have the lowest scores on most abilities.
The following cognitive abilities are assessed: dexterity (connecting numbers), spatial orientation (drawing a cube), visual construction skills (drawing a clock and marking a certain time), naming an animal, memory, attention, repeating sentences, recalling words, abstraction, later acquisition of words, orientation. The test takes approximately ten minutes to complete and a maximum of 30 points can be obtained. It is mainly used in the detection of the early phase of Alzheimer's dementia and mild cognitive impairment, but also Parkinson's disease, Huntington's disease, vascular cognitive disorders, brain metastases, primary brain tumors, multiple sclerosis, depression, schizophrenia, etc. MoCA has a relatively wide range of uses, as it evaluates multiple cognitive domains, and thus can be useful in the detection of various neurological diseases. Currently, the MoCA test is still used more as a supplement to the MMSE test. This test, together with others such as the MMSE ("Minimental State Examination"), the Addenbrooke's cognitive test or the "7-minute" test, is among the cognitive screening tests used to diagnose dementia. Currently, there is already a seventh version of the original test, which can be freely obtained in 55 different languages. It remains unclear, however, how to interpret its scores over time and distinguish age-associated cognitive decline (AACD) from early neurodegeneration. It was introduced to the Czech environment in 2006 by J. The Montreal Cognitive Assessment (MoCA) is an established cognitive screening tool in older adults. Ziad Nasreddine, and subsequently published it in 2005 (Nasreddineet al., 2005). The Montreal Cognitive Assessment (MoCA, also Nasreddin's test) was developed in 1996 by a Canadian specialist in cognitive disorders and Alzheimer's disease, Dr.